The World’s First AI-Designed Long-Acting GLP-1 Weight Loss Drug to Be Launched by Intelligent Medicine Original
Intelligent Medicine Original, leveraging its proprietary AI drug design platform TranProteins, has successfully developed a GLP-1 receptor agonist (GLP-1 RA) with an extended half-life and enhanced efficacy. The next-generation GLP-1 RA boasts a half-life (T1/2) three times longer than semaglutide,…